Market Cap 1.75M
Revenue (ttm) 0.00
Net Income (ttm) -10.38M
EPS (ttm) N/A
PE Ratio 0.04
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 173,800
Avg Vol 509,222
Day's Range N/A - N/A
Shares Out 2.05M
Stochastic %K 3%
Beta -0.28
Analysts Strong Sell
Price Target $8.00

Company Profile

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 an...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 652 4500
Address:
1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States
BigShizzle54
BigShizzle54 Jun. 9 at 8:47 PM
$ATXI next up is >>>> 🔥 $$CARM
1 · Reply
ihatemoney
ihatemoney May. 28 at 3:14 AM
$ATXI I don’t think there are enough sellers to short and enough buyers to sell
0 · Reply
chikev
chikev May. 26 at 6:56 PM
$ATXI Anyone think it will go over $1? Or are we anticipating a split at some point?
0 · Reply
the_real_Joker
the_real_Joker May. 15 at 8:10 AM
$ATXI Should you be ashamed to robbing from a body?
0 · Reply
the_real_Joker
the_real_Joker May. 13 at 9:44 PM
$ATXI a jump in point here b4 shorta$S's covering.
0 · Reply
Zellchair
Zellchair May. 5 at 1:51 PM
$TGTX $DERM $CKPT $MBIO $ATXI Since I write several long paragraphs about these tickers in my review, I should have permission to share this.
0 · Reply
JMJTrading
JMJTrading May. 2 at 6:00 PM
$BLMZ Bullish, with the charts and in my own research, there is every reason to be bullish and no negatives at all. Its a win/win. Next big squeeze $$$ Doing well - $CLIK $ATXI $CNSP
0 · Reply
SimSimBola
SimSimBola Apr. 30 at 8:59 PM
$ATXI still something in for current holders if aj201 succeeds. I wonder what's taking so long for the trial results. The Taiwanese seemed to have had some merit in their claims. Congratulations shorties... Congratulations Armistice, u POS; anything u touch these days collapses.
0 · Reply
Zellchair
Zellchair Apr. 30 at 8:47 PM
$FBIO $FBIOP $ATXI https://ir.avenuetx.com/sec-filings/all-sec-filings/content/0001104659-25-042570/0001104659-25-042570.pdf
0 · Reply
wehavethem62
wehavethem62 Apr. 28 at 10:10 PM
$ATXI Another criminal enterprise
0 · Reply
Latest News on ATXI
No data available.
BigShizzle54
BigShizzle54 Jun. 9 at 8:47 PM
$ATXI next up is >>>> 🔥 $$CARM
1 · Reply
ihatemoney
ihatemoney May. 28 at 3:14 AM
$ATXI I don’t think there are enough sellers to short and enough buyers to sell
0 · Reply
chikev
chikev May. 26 at 6:56 PM
$ATXI Anyone think it will go over $1? Or are we anticipating a split at some point?
0 · Reply
the_real_Joker
the_real_Joker May. 15 at 8:10 AM
$ATXI Should you be ashamed to robbing from a body?
0 · Reply
the_real_Joker
the_real_Joker May. 13 at 9:44 PM
$ATXI a jump in point here b4 shorta$S's covering.
0 · Reply
Zellchair
Zellchair May. 5 at 1:51 PM
$TGTX $DERM $CKPT $MBIO $ATXI Since I write several long paragraphs about these tickers in my review, I should have permission to share this.
0 · Reply
JMJTrading
JMJTrading May. 2 at 6:00 PM
$BLMZ Bullish, with the charts and in my own research, there is every reason to be bullish and no negatives at all. Its a win/win. Next big squeeze $$$ Doing well - $CLIK $ATXI $CNSP
0 · Reply
SimSimBola
SimSimBola Apr. 30 at 8:59 PM
$ATXI still something in for current holders if aj201 succeeds. I wonder what's taking so long for the trial results. The Taiwanese seemed to have had some merit in their claims. Congratulations shorties... Congratulations Armistice, u POS; anything u touch these days collapses.
0 · Reply
Zellchair
Zellchair Apr. 30 at 8:47 PM
$FBIO $FBIOP $ATXI https://ir.avenuetx.com/sec-filings/all-sec-filings/content/0001104659-25-042570/0001104659-25-042570.pdf
0 · Reply
wehavethem62
wehavethem62 Apr. 28 at 10:10 PM
$ATXI Another criminal enterprise
0 · Reply
omega42
omega42 Apr. 24 at 2:48 PM
$MBIO fukery taking place 17M shares traded. pumping/dumping taking place. The company will file something later today. So glad i exited this and $ATXI disasters.
0 · Reply
Vax_Ryder
Vax_Ryder Apr. 22 at 6:42 AM
$ATXI what happened to the Company?
0 · Reply
Bazzzigar
Bazzzigar Apr. 11 at 6:50 PM
$ATXI WINT
0 · Reply
Zellchair
Zellchair Apr. 11 at 4:36 PM
$FBIO In ROTH's previous analysis, they value Fortress' ownership as follows: Avenue - $ATXI: $0M Checkpoint - $CKPT: $9M Mustang - $MBIO: $3M Total: $12M If Checkpoint's buyout just goes through, we can value that part to at least $28M right away without even factoring in a single possible CVR or FBIO earning a single $ on the 2.5% in royalties from Checkpoint's portfolio/pipeline. As I've mentioned in previous posts, there is value in Mustang and Avenue if you're just going to base it on the study results they've achieved to date, but, due to various circumstances, I think it's safest to write these values ​​down to $0 for now. New minimum total: $28M That's more than twice as high as when ROTH set a PT of $13 for all of Fortress.
0 · Reply
SimSimBola
SimSimBola Apr. 2 at 8:16 PM
$ATXI seems like Fortress is bullish! Check latest filing. Shares acquired.
0 · Reply
d_risk
d_risk Apr. 1 at 7:14 PM
$ATXI - AVENUE THERAPEUTICS, INC. - 10K - Updated Risk Factors ATXI's 2025 10-K Risk Factors highlight increased reliance on third-party manufacturers, post-marketing risks, AI challenges, financial strain, geopolitical tensions, and potential conflicts with Fortress, alongside new market and regulatory hurdles. #ManufacturingRisks #RegulatoryHurdles #FinancialStrain #GeopoliticalTensions #AIChallenges 🟢 Added 🟠 Removed https://d-risk.ai/ATXI/10-K/2025-03-31
0 · Reply
Zellchair
Zellchair Mar. 26 at 9:08 AM
$FBIO Fortress Biotech – Assets/Sum of parts - Part 8A 3. Subsidiaries without significant value today that should only be valued as a future bonus Mustang $MBIO – 12% (probably lower today), 4.5% Royalty, 2.5% Annual Equity Dividend Avenue $ATXI - 14% (probably lower today), 4.5% Royalty, 2.5% Annual Equity Dividend Cellvation – 79.2%, 4.5% Royalty, 2.5% Annual Equity Dividend Oncogenuity – 73,5%, 4.5% Royalty, 2.5% Annual Equity Dividend Aevitas – (Sold) Eligible to ~$140M in potential late-stage development for 4D-175, regulatory and sales milestone payments plus royalties from $FDMT From Q4 2024 (28/2-2025): “Paused significant additional capital allocation and investment, pending additional financing or partnerships for the following therapeutics: 4D-175 for geographic atrophy … “
0 · Reply
TBoneP
TBoneP Mar. 25 at 2:45 PM
$ATXI RIP
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 3:43 AM
$ATXI Digging the neurotherapeutics play. AJ201 trial data end of 2024 could be huge catalyst. IV tramadol Phase 3 incoming. Baergic acquisition adds nice optionality. Watching closely for next moves. Potential multi-bagger if clinical results hit. excellent article: https://beyondspx.com/article/breakthrough-neurotherapeutics-the-compelling-story-of-avenue-therapeutics-atxi
0 · Reply
Bazzzigar
Bazzzigar Mar. 20 at 4:48 PM
$ATXI any date for delisting yet
1 · Reply